Pharmadrug Inc. Pharmadrug Inc.

Pharmadrug Inc.

PHRX

Rank in Stocks #39390
Pharmadrug Inc., a Toronto-based specialty pharmaceutical firm, is dedicated to... Pharmadrug Inc., a Toronto-based specialty pharmaceutical firm, is dedicated to the research, development, and market introduction of controlled substances and natural therapeutics, such as psychedelics, cannabis, and other approved compounds derived from nature. The company also manages the import and supply of medical cannabis to pharmacies across Germany and the broader European Union. Additionally, it operates Super Smart, an entity focused on advancing the application of functional and psilocybin mushrooms, and engages in studies to reformulate established natural medicines. Pharmadrug maintains key research collaborations, including an agreement with the University of Michigan to explore the potential role of N, N-dimethyltryptamine (DMT) in various states of consciousness. It has also partnered with the Southwest Research Institute for the manufacturing of cepharanthine and entered into a clinical trial agreement with Johns Hopkins University to compare the acute and enduring psychological and neural effects of DMT against another potent active molecule. The company adopted its current name in October 2019, having previously operated as Aura Health Inc.
Share Price
$0.00355676
Market Cap
$477.37K
Change (1 day)
-3.08%
Change (1 year)
-52.51%
Country
CA
Trade Pharmadrug Inc. (PHRX)

Category

Healthcare
Stock price history for Pharmadrug Inc. (PHRX)
Highest end of day price: $0.00 on 2026-10-01

Lowest end of day price: $1.06 on 2017-05-01
Stock price history of Pharmadrug Inc. from 2017 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -22.18%
2025 40.10%
2024 -75.33%
2023 -52.90%
2022 -58.56%
2021 -55.33%
2020 190.51%
2019 -85.31%
2018 25.03%
2017 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$161.15 21.02%
DE
$41.46 47.41%
JP
$212.49 23.19%
CH
$19.19 -0.09%
IN